Shawn Titcomb

Shawn focuses on biotechnology, specialty pharmaceuticals and new technologies in life sciences. Previously, he served as Head of Investment and Merchant Banking at Noble Life Science Partners, a division of Noble Capital Markets. Prior to Noble, he was a Founding Partner at Variant Research Corporation and Senior Vice President of Avalon Research Group, both of which focused on long and short life sciences equity research.​

Shawn is highly proficient in scientific and corporate due diligence and leverages proprietary relationships with scientific key opinion leaders and life science executives. For more than 20 years, he has demonstrated an ability to create and identify emerging life sciences companies with successful management teams, milestone outcomes and investment returns. Shawn has invested and raised capital for life sciences companies that has resulted in significant shareholder equity and valuations of over $1 billion.

Shawn earned his degree in Business Administration from the University of Denver. Shawn also serves as a Managing Director on Wilmington Capital Securities’ Life Sciences Investment Banking Division and holds FINRA series 7, 63 and 79 licenses​.